Position increased In Endologix Inc By Arrowmark Colorado Holdings Llc

Endologix, Inc. (NASDAQ:ELGX) Corporate Logo

Big Money Sentiment decreased to 1.15 in Q3 2018. It has change of 0.20, from 2018Q2’s 1.35. The ratio worsened due to Endologix, Inc. positioning: 18 sold and 23 reduced. 21 funds took stakes and 26 increased stakes. Investors holded 77.82 million in 2018Q2 but now own 76.15 million shares or 2.15% less.

34,493 are owned by Voya Invest Mngmt Lc. Mpm Asset Mgmt Ltd Company has invested 1.45% in Endologix, Inc. (NASDAQ:ELGX). Palisade Capital Management Limited Liability Corporation Nj owns 1.59 million shs for 0.08% of their capital. Wells Fargo & Co Mn, a California-based fund reported 150,424 shs. Vanguard Gp has invested 0% in Endologix, Inc. (NASDAQ:ELGX). Arrowmark Colorado Ltd Liability Corporation holds 0.16% or 10.28 million shs. Florida-based State Board Of Administration Of Florida Retirement has invested 0% in Endologix, Inc. (NASDAQ:ELGX). Moreover, Millennium Management Ltd Liability Corporation has 0% invested in Endologix, Inc. (NASDAQ:ELGX). California State Teachers Retirement reported 0% of its capital in Endologix, Inc. (NASDAQ:ELGX). Schwab Charles Management Inc holds 0% or 418,742 shs in its capital. Mackenzie Fincl reported 1.70 million shs. 83,600 were accumulated by California Public Employees Retirement Systems. Invesco Limited invested in 58,556 shs. Raymond James Serv Advsrs has invested 0% in Endologix, Inc. (NASDAQ:ELGX). Cortina Asset Management Limited Liability invested 0.05% of its capital in Endologix, Inc. (NASDAQ:ELGX).

Arrowmark Colorado Holdings Llc reported increased Interest in Endologix Inc

By clicking the link 000117266119000542 you will find SC 13G/A SEC report submitted by Arrowmark Colorado Holdings Llc about Endologix Inc .As reported by Arrowmark Colorado Holdings Llc, the filler increased its stake in the stock by 4.69 % for 10,376,633 shares.On December 31, 2018 Arrowmark Colorado Holdings Llc has 10% of the Health Care- stock.

The institutional investor looks more positive with $5.56 billion after such an increase of its Endologix Inc ownership.

Endologix Inc Institutional Changes

85 investors own Endologix Inc says the latest Sec.gov filings. In Q3 2017 the institutional ownership is high, which is Infinity of the outstanding shares. By 2978544 shares it is increased. Institutional investors held 83133192. In total 17 funds opened new Endologix Inc stakes, 29 increased stakes. There were 21 that closed positions and 22 reduced them.

Here’s the stocks most Well-known investors in which it takes place: Mpm Asset Management Llc..

The first, Senzar Asset Management Llc is holding 901541 shares as of Q3 2017 for 0.98% of its portfolio. The next Camber Capital Management Llc has 8000000 shares or 2.26% of its portfolio. 1121447 shares has MA Mpm Asset Management Llc which is 2.44% of their stock portfolio. Essex Woodlands Health Ventures Inc reported stake worth 2.03% of its US stock portfolio. Further, the 1253647 shares are held by NJ Palisade Capital Management Llc. Endologix Inc is 0.20% of the manager´┐Żs US portfolio.

Arrowmark Colorado Holdings Llc website.

Endologix, Inc. (NASDAQ:ELGX)’s quarterly earnings will be revealed on February, 20., according to Faxor. This year’s earnings per share analyst estimate is expected to be $-0.20. That is 150.00 % down compareed to $-0.08 earnings per share for last year. Wall Street now sees 33.33 % negative EPS growth despite Endologix, Inc. last quarter’s EPS of $-0.15.

ELGX is reaching $0.5803 during the last trading session, after decreased 2.81%.Currently Endologix, Inc. is downtrending after 87.86% change in last February 14, 2018. ELGX has also 391,129 shares volume. The stock underperformed the S&P500 by 87.86%.

Endologix, Inc. develops, manufactures, markets, and sells medical devices for the treatment of abdominal aortic aneurysms in the United States and internationally.The firm is worth $60.03 million. It offers minimally-invasive endovascular repair products, including AFX (Anatomical Fixation) endovascular AAA system, which is a minimally invasive delivery system; VELA Proximal Endograft, which is designed for the treatment of proximal aortic neck anatomies with AFX; and the ovation abdominal stent graft system.Last it reported negative earnings. The firm also provides endovascular sealing (EVAS) product that is based on the Nellix EVAS system to seal the aneurysm, and provides blood flow to the legs through two blood lumens.

For more Endologix, Inc. (NASDAQ:ELGX) news posted recently go to: Zacks.com, Benzinga.com, Businesswire.com, Seekingalpha.com or Benzinga.com. The titles are as follows: “Endologix (ELGX) Reports Q3 Loss, Tops Revenue Estimates – Zacks.com” posted on November 01, 2018, “25 Stocks Moving In Wednesday’s Pre-Market Session – Benzinga” on October 03, 2018, “Endologix Appoints Jeffrey S. Brown as Chief Operations Officer – Business Wire” with a publish date: August 15, 2018, “Endologix recalls Endovascular AAA System due to endoleak risk – Seeking Alpha” and the last “The Daily Biotech Pulse: Big Miss For Seattle Genetics (NASDAQ:SGEN); Hematology Conference Presentations; Gossamer Bio, Harpoon IPOs – Benzinga” with publication date: February 08, 2019.

Endologix, Inc. (NASDAQ:ELGX) Institutional Investors Chart

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.